Thoratec scooped up by St. Jude for $3.5bn

09 Sep 2020

St. Jude Medical Inc. paid $3.5bn or $63.50 per share (a 34% premium) for fellow public cardiovascular-focused device firm Thoratec Corp.

Medical Devices
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
  - Minimally or Less Invasive

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Thoratec scooped up by St. Jude for $3.5bn

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice